Transaction in Own Shares

Summary by AI BETAClose X

QinetiQ Group plc has announced the purchase of 613,000 ordinary shares for cancellation between April 13 and April 17, 2026, as part of its ongoing share buyback program. These purchases were executed across various trading venues, with weighted average prices ranging from 475.24 GBp to 485.40 GBp. Following these transactions, the company's total number of ordinary shares in issue and total voting rights will be 523,387,471.

Disclaimer*

QinetiQ Group plc
21 April 2026
 

QinetiQ Group plc

Transaction in own shares

QinetiQ Group plc (the Company) announces that in the period 13 April 2026 to 17 April 2026 it purchased in aggregate 613,000 ordinary shares of 1 pence each (Shares) for cancellation through Deutsche Bank AG, London Branch (trading for these purposes as Deutsche Numis), in accordance with the authority granted by shareholders at the Annual General Meeting of the Company held on 17 July 2025, and pursuant to the latest tranche of its existing share buyback programme announced on 25 March 2026. Full details are set out below:

                                                                                                                     

Date

Venue

Weighted average price paid per share (GBp)

Aggregate number of shares purchased

Lowest price paid per share (GBp)

Highest price paid per share (GBp)

13 April 2026

London Stock Exchange

475.5289

80,000

471.40

480.00

Chi-X

(CXE)

475.3087

20,000

471.10

480.00

BATS

(BXE)

475.2407

25,000

471.30

479.60

14 April 2026

London Stock Exchange

479.2512

80,000

476.00

482.30

Chi-X

(CXE)

479.2202

20,000

476.20

481.80

BATS

(BXE)

479.2900

25,000

476.20

481.70

15 April 2026

London Stock Exchange

483.83

75,000

479.80

486.60

Chi-X

(CXE)

483.95

20,000

480.50

486.50

BATS

(BXE)

484.08

25,000

481.40

486.50

16 April 2026

London Stock Exchange

483.42

80,000

475.10

490.20

Chi-X

(CXE)

484.27

20,000

475.10

489.70

BATS

(BXE)

483.06

23,000

475.40

490.30

17 April 2026

London Stock Exchange

484.96

80,000

479.40

490.50

Chi-X

(CXE)

485.08

20,000

481.40

489.80

BATS

(BXE)

485.40

20,000

481.30

489.30

 

All shares purchased by the Company will be cancelled. 

Following settlement of the above transactions, the Company's total number of ordinary shares in issue, and its total voting rights, will be 523,387,471 ordinary shares. This figure may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest, or a change to their interest, in the Company under the Financial Conduct Authority's Disclosure and Transparency Rules. The Company does not hold any ordinary shares in treasury.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014, as amended, a full breakdown of the individual trades made by Deutsche Numis on behalf of the Company is available via the link below.


http://www.rns-pdf.londonstockexchange.com/rns/2011B_1-2026-4-20.pdf

 

This announcement will also be available on QinetiQ Group plc's website at: https://www.qinetiq.com/en/investors.

Enquiries to:

Andrew Carter, Group Director Investor Relations:

+44 (0) 7392 289116

Stephanie Mann, Group Head of Media Relations:

+44 (0) 7770 720268

James Field, Company Secretary:

+44 (0) 7841 662957

 

LEI: 213800S8OBDOZMCMUW34

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings